Why Get Tested?

More people die from cardiovascular disease (CVD) than from any other cause. CVD includes chest pain (angina), heart attack (myocardial infarction) and stroke. Many cases of cardiovascular disease can be prevented by adopting a healthy lifestyle, or by medications, but to manage these factors, people at high and intermediate risk need to be detected.


Currently, conventional risk factors, such as whether an individual smokes or has a family history of CVD, are analysed to predict the risk of a CVD event occurring in the next 10 years. Increasingly, genetic factors are being implicated in CVD, and it is becoming clear that assessing a person’s genetic makeup is an important component of providing a true picture of individual risk. 

Expanding Our Testing Service

Cardiovascular disease (CVD) is the greatest cause of death in the developed world. CVD is a broad term for a wide range of diseases that affect the heart and blood vessels. StoreGene's unique Cardiovascular Risk Profiling service is designed to accurately estimate an individual's risk of suffering a unspecified CVD event in the next 10 years. However, we are also developing testing services that will allow us to estimate an individual's risk of developing specific cardiovascular diseases and cardiovascular associated diseases over a given time frame. Along with our current Cardiovascular Risk Profiling service, we are currently offering testing for FH, a genetic based disease that leads to high cholesterol levels. In addition, we are currently developing risk profiling test services for Abdominal aortic aneurysm (AAA) and Type 2 diabetes (T2D).


How to access StoreGene's testing service?  

StoreGene currently offers its exclusive testing service through our growing network of partner healthcare providers. Each healthcare provider is assessed for its suitability to offer StoreGene's testing service. As part of our service we provide physicians with the necessary training to accurately interpret each client's report which details their results and any associated risks. StoreGene's operating structure of maintaining the physician to client relationship ensures that each client report can be comprehensively explained with any client queries addressed immediately, in person. Contact us to learn more about our testing services or see a list of our current service providers below.  


Questions Answered

A. The client’s saliva/blood sample will be sent to the research team to be processed in the StoreGene laboratory. Here, DNA will be extracted from cells contained in the sample for the purpose of genetic risk profiling. This information will be combined with the information provided about health and lifestyle, to give an overall combined estimate of risk of cardiovascular disease (CVD) in the next 10 years.

Q. What will happen to my saliva/blood sample? 

Q. What is client-identifiable information?

Q. What is anonymised client information?

Q. Who will see the risk results?

Q.What is done with the information obtained from collected saliva/blood by StoreGene? 

Q. Who is the average person a client is compared with?

Q. Do clients have to disclose their test result to insurers?